CN108420868B - Chinese herbal medicine foot-bath medicine for treating primary hypertension - Google Patents
Chinese herbal medicine foot-bath medicine for treating primary hypertension Download PDFInfo
- Publication number
- CN108420868B CN108420868B CN201810583983.4A CN201810583983A CN108420868B CN 108420868 B CN108420868 B CN 108420868B CN 201810583983 A CN201810583983 A CN 201810583983A CN 108420868 B CN108420868 B CN 108420868B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- functions
- chinese herbal
- herbal medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/235—Foeniculum (fennel)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese herbal medicine foot bath medicine for treating primary hypertension, which is characterized by comprising the following components in parts by weight: 28-32 parts of folium artemisiae argyi, 12-18 parts of fennel, 28-32 parts of rhizoma corydalis, 28-32 parts of radix achyranthis bidentatae, 28-32 parts of uncaria, 28-32 parts of cortex albiziae, 28-32 parts of caulis polygoni multiflori and 28-32 parts of ligusticum wallichii. In the formula, uncaria rhynchophylla has the functions of clearing heat and calming endogenous wind, calming the liver and suppressing yang, corydalis tuber, cortex albiziae and ligusticum wallichii have the functions of activating blood and promoting qi circulation and dredging collaterals, soothing the liver and relieving depression, vine of multiflower knotweed has the functions of soothing the heart and soothing the nerves, folium artemisiae argyi and fennel have the functions of warming and activating channels and dredging collaterals, guiding fire to return to original origin, and radix achyranthis bidentatae has the functions of guiding various medicines to descend, and the whole; the foot bath with the formula can effectively reduce blood pressure, improve complications of patients such as headache, dizziness, insomnia and the like, and improve the living quality of the patients.
Description
Technical Field
The invention relates to the technical field of Chinese herbal medicine formulas, in particular to a Chinese herbal medicine foot bath medicine for treating essential hypertension.
Background
Hypertension is a clinical syndrome characterized by an increase in systemic arterial blood pressure, which may be accompanied by functional or organic lesions in organs such as heart, brain, and kidney. Hypertension is the most common chronic disease, and in the absence of any antihypertensive drug, the systolic pressure is greater than or equal to 140 mm Hg, and the diastolic pressure is greater than or equal to 90 mm Hg, and the hypertension can be generally divided into primary hypertension and secondary hypertension.
The primary hypertension has high prevalence rate, is the most main risk factor of cardiovascular and cerebrovascular diseases, and the coronary heart disease, stroke and chronic pathological changes of kidney are the main complications of hypertension. Western medicines have definite blood pressure reducing effect, but need long-term and combined medication, and partial patients who take the medicines have liver and kidney function damage, so that the curative effect on improving the living quality of the patients, such as dizziness, headache and insomnia, is not ideal.
Secondary hypertension, also called symptomatic hypertension, has a clear cause in this disease, hypertension is only one of the clinical manifestations of the disease, and blood pressure can rise temporarily or permanently.
In the invention patent with publication number CN103599396A, a traditional Chinese medicine formula for treating hypertension is disclosed, which relates to the technical field of medicines for treating hypertension, and is characterized in that: the composition comprises the following components: the traditional Chinese medicine composition comprises, by weight, 40-50 parts of eucommia ulmoides, 25-35 parts of ligusticum wallichii, 25-35 parts of rhizoma alismatis, 20-40 parts of rhizoma atractylodis, 10-15 parts of dipsacus root, 10-30 parts of sweet potato pulp, 5-15 parts of uncaria, 5-15 parts of gastrodia elata, 50-70 parts of raw astragalus membranaceus, 15-25 parts of salvia miltiorrhiza, 25-35 parts of radix ophiopogonis and 10-20 parts of radix pseudostellariae. The invention can treat hypertension, reduce incidence and death rate of cardiovascular and cerebrovascular diseases to the utmost extent, prolong the life of patients, and has good drug property, good safety, pure nature, no pollution and no side effect.
However, the oral traditional Chinese medicine formula is slow in effect, has certain toxic and side effects after being taken for a long time, has certain bitter taste, and may influence the life of patients.
The traditional Chinese medicine theory of meridians and collaterals considers that the feet are the gathering parts of the three yin meridians and the three yang meridians of the feet, and maintain the circulation of qi and blood of the meridians and collaterals of the five zang-organs and six fu-organs. The channels and collaterals are used for dredging, and the medicines stimulate the qi and blood circulation of the channels and collaterals of the feet, so that the normal functions of the five viscera and the six fu organs can be regulated.
The traditional Chinese medicine foot bath is an external treatment method for local infiltration of traditional Chinese medicines under the guidance of the theory of traditional Chinese medicine, can lead fire to return to origin, dredge channels and collaterals, harmonize yin and yang, has obvious curative effects on reducing blood pressure, improving headache, dizziness and insomnia of patients, and can obviously improve the living quality of the patients.
Disclosure of Invention
Aiming at the defects in the technology, the invention provides a Chinese herbal medicine foot-bath medicine for treating primary hypertension, wherein uncaria rhynchophylla in the formula has the functions of clearing heat and calming endogenous wind, calming the liver and suppressing yang, corydalis tuber, cortex albiziae and ligusticum wallichii have the functions of activating blood and promoting qi circulation and dredging collaterals, soothing liver and relieving depression, tuber fleeceflower stem has the functions of soothing the heart and calming the nerves, folium artemisiae argyi and fennel have the functions of warming and activating the channels and collaterals, guiding fire to return origin, and radix achyranthis bidentatae leads the medicines to descend; the foot bath with the formula can effectively reduce blood pressure, improve complications of patients such as headache, dizziness, insomnia and the like, and improve the living quality of the patients.
The invention also aims to provide the Chinese herbal medicine foot bath medicine for treating the essential hypertension, the formula comprises eight Chinese herbal medicine components, and the medicine is used for foot bath before sleep for patients with the essential hypertension, is simple and convenient to operate, and can effectively reduce the blood pressure after long-term use.
In order to achieve the above object, the technical solution of the present invention is as follows.
The Chinese herbal medicine foot bath medicine for treating primary hypertension is characterized by comprising the following components in parts by weight:
28-32 parts of folium artemisiae argyi, 12-18 parts of fennel, 28-32 parts of rhizoma corydalis, 28-32 parts of radix achyranthis bidentatae, 28-32 parts of uncaria, 28-32 parts of cortex albiziae, 28-32 parts of caulis polygoni multiflori and 28-32 parts of ligusticum wallichii.
According to the invention, eight Chinese herbal medicine components are added into the formula, 8-10 times of water is added for decoction, the decoction is taken after the water is boiled for about 10-30 minutes, the feet are bathed for 20-30 minutes while the decoction is hot, and the feet are bathed once before sleeping every day, so that the blood pressure of a patient with primary hypertension can be effectively reduced, the complications of headache, dizziness, insomnia and the like of the patient can be improved through conditioning of the formula, the oral administration is not required, the use is convenient, and the foot bathing also has certain safety.
Further, the formula comprises the following components in parts by weight:
30 parts of folium artemisiae argyi, 15 parts of fennel, 30 parts of corydalis tuber, 30 parts of radix achyranthis bidentatae, 30 parts of uncaria, 30 parts of cortex albiziae, 30 parts of caulis polygoni multiflori and 30 parts of ligusticum wallichii.
Further, the formula comprises the following components in parts by weight:
28 parts of folium artemisiae argyi, 14 parts of fennel, 28 parts of corydalis tuber, 28 parts of achyranthes bidentata, 28 parts of uncaria, 28 parts of cortex albiziae, 28 parts of caulis polygoni multiflori and 28 parts of ligusticum wallichii.
The invention has the beneficial effects that: compared with the prior art, the Chinese herbal medicine foot-bath medicine for treating essential hypertension, provided by the invention, has the effects of clearing away heat, calming endogenous wind, calming the liver, suppressing yang hyperactivity, activating blood, promoting qi circulation, dredging collaterals, soothing liver, relieving depression, soothing the heart and tranquilizing mind by using the vine of multiflower knotweed, warming and activating meridians by using the folium artemisiae argyi and the fennel, guiding fire to return origin, reducing the number of medicines by using the radix achyranthis bidentatae, and playing the effects of promoting qi, activating blood, calming the liver and suppressing yang hyperactivity together in the whole formula; the foot bath with the formula can effectively reduce blood pressure, improve complications of patients such as headache, dizziness, insomnia and the like, and improve the living quality of the patients; the formula comprises eight Chinese herbal medicine components, and aims at essential hypertension patients, the foot bath is performed before sleep, the operation is simple and convenient, and the blood pressure can be effectively reduced after long-term use.
Detailed Description
The present invention will be described in further detail in order to make the objects, technical solutions and advantageous effects of the present invention more apparent. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
Example 1
A Chinese herbal medicine foot bath medicine for treating primary hypertension comprises the following components: 30g of folium artemisiae argyi, 15g of fennel, 30g of rhizoma corydalis, 30g of radix achyranthis bidentatae, 30g of uncaria, 30g of cortex albiziae, 30g of caulis polygoni multiflori and 30g of ligusticum wallichii.
Case 1
The Chinese herbal medicine foot bath medicine provided by the invention is used, the Chinese herbal medicine components in the formula are added with 2000ml of water for decoction one hour before sleeping every night, the decoction is boiled for 10-30 minutes, the medicine juice is taken for foot bath for 20-30 minutes while the medicine juice is warm, the foot is soaked until the foot sweats slightly, the blood pressure is obviously reduced, the dizziness symptom disappears, the sleep quality is obviously improved, and the recurrence is not seen after two years of follow-up visit under the condition that other hypotensor is not taken.
Example 2
A Chinese herbal medicine foot bath medicine for treating primary hypertension comprises the following components: 28g of folium artemisiae argyi, 14g of fennel, 28g of rhizoma corydalis, 28g of radix achyranthis bidentatae, 28g of uncaria, 28g of cortex albiziae, 28g of caulis polygoni multiflori and 28g of ligusticum wallichii.
Case 2
According to the Chinese herbal medicine foot bath medicine provided by the invention, the Chinese herbal medicine components in the formula are added with 2000ml of water for boiling one hour before sleeping every night, the mixture is boiled for 10-30 minutes after the water is boiled, the medicine juice is taken to warm and bath the feet for 20-30 minutes, the feet are soaked until sweating slightly, the symptoms of headache, red tongue and dry mouth disappear, the sleep quality is obviously improved, and the recurrence is not seen after the follow-up for two years under the condition that other hypotensor is not taken.
The above disclosure is only for a few specific embodiments of the present invention, but the present invention is not limited thereto, and any variations that can be made by those skilled in the art are intended to fall within the scope of the present invention.
Claims (3)
1. The Chinese herbal medicine foot bath medicine for treating primary hypertension is characterized by comprising the following components in parts by weight:
28-32 parts of folium artemisiae argyi, 12-18 parts of fennel, 28-32 parts of rhizoma corydalis, 28-32 parts of radix achyranthis bidentatae, 28-32 parts of uncaria, 28-32 parts of cortex albiziae, 28-32 parts of caulis polygoni multiflori and 28-32 parts of ligusticum wallichii.
2. The Chinese herbal medicine footbath medicine for treating primary hypertension according to claim 1, which is characterized by comprising the following components in parts by weight:
30 parts of folium artemisiae argyi, 15 parts of fennel, 30 parts of corydalis tuber, 30 parts of radix achyranthis bidentatae, 30 parts of uncaria, 30 parts of cortex albiziae, 30 parts of caulis polygoni multiflori and 30 parts of ligusticum wallichii.
3. The Chinese herbal medicine footbath medicine for treating primary hypertension according to claim 1, which is characterized by comprising the following components in parts by weight:
28 parts of folium artemisiae argyi, 14 parts of fennel, 28 parts of corydalis tuber, 28 parts of achyranthes bidentata, 28 parts of uncaria, 28 parts of cortex albiziae, 28 parts of caulis polygoni multiflori and 28 parts of ligusticum wallichii.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810583983.4A CN108420868B (en) | 2018-06-08 | 2018-06-08 | Chinese herbal medicine foot-bath medicine for treating primary hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810583983.4A CN108420868B (en) | 2018-06-08 | 2018-06-08 | Chinese herbal medicine foot-bath medicine for treating primary hypertension |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108420868A CN108420868A (en) | 2018-08-21 |
| CN108420868B true CN108420868B (en) | 2021-01-12 |
Family
ID=63164762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810583983.4A Expired - Fee Related CN108420868B (en) | 2018-06-08 | 2018-06-08 | Chinese herbal medicine foot-bath medicine for treating primary hypertension |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108420868B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104013702A (en) * | 2014-06-23 | 2014-09-03 | 王永霞 | Traditional Chinese medicine for fumigation foot bath to treat high blood pressure |
| CN105194355A (en) * | 2015-11-12 | 2015-12-30 | 青岛华之草医药科技有限公司 | Traditional Chinese medicine preparation for treating primary hypertension |
-
2018
- 2018-06-08 CN CN201810583983.4A patent/CN108420868B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104013702A (en) * | 2014-06-23 | 2014-09-03 | 王永霞 | Traditional Chinese medicine for fumigation foot bath to treat high blood pressure |
| CN105194355A (en) * | 2015-11-12 | 2015-12-30 | 青岛华之草医药科技有限公司 | Traditional Chinese medicine preparation for treating primary hypertension |
Non-Patent Citations (1)
| Title |
|---|
| 畅达治疗高血压病经验;南晋生等;《中国民间疗法》;20120930;第20卷(第09期);第11-12页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108420868A (en) | 2018-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103055116B (en) | Traditional Chinese medicine composition for treating acnes | |
| CN103301426A (en) | Capsule for invigorating circulation and benefiting heart | |
| CN104667047A (en) | Traditional Chinese medicine liquor for treating diabetic feet | |
| CN103301356B (en) | Preparation method of enema for chronic renal failure | |
| TW202406564A (en) | A chinese medicinal composition and its application | |
| CN105055915A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN103919910A (en) | Medicine for treating coronary heart disease | |
| CN103550717A (en) | Traditional Chinese medicine for treating pneumonia | |
| CN103301355A (en) | Preparation method of chronic renal failure colon dialysate | |
| CN108420868B (en) | Chinese herbal medicine foot-bath medicine for treating primary hypertension | |
| CN105687788A (en) | Pharmaceutical composition capable of softening blood vessels and application thereof | |
| CN104825736A (en) | Traditional Chinese medicine for treating hepatitis B | |
| CN103860773A (en) | Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof | |
| CN103705900A (en) | Traditional Chinese medicine composition for treating hypertension | |
| WO2020107226A1 (en) | Traditional chinese medicine composition, preparation method therefor, and application thereof | |
| CN105031350A (en) | Traditional Chinese medicine for treating hypertensive heart disease and preparation method for traditional Chinese medicine | |
| CN104740465A (en) | Traditional Chinese medicine composition for treating allergic rhinitis | |
| CN104208442A (en) | Traditional Chinese medicine for treating meniere disease and preparation method thereof | |
| KR101543760B1 (en) | Pharmaceutical composition for preventing and treatmenting stroke and thrombus containing traditional medical herbs | |
| CN103768422A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN102940833B (en) | Traditional Chinese medicine composition for treating coronary heart disease and preparation method thereof | |
| CN104644916A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN105688071A (en) | Traditional Chinese medicine for treating interstitial lung disease | |
| CN106389821A (en) | Traditional Chinese medicine preparation for treatment of blood transfusion hemolytic reaction and preparation method thereof | |
| CN105709087A (en) | Orally administered drug for treating infantile night sweat and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210112 |